International Flavors & Fragrances
Creates flavors, fragrances, enzymes, cultures, probiotics, and specialty bioscience ingredients for manufacturers.
$83.37
After-hours close−4.57 (−5.20%)
At close$87.95(+1.26%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 124.15%Insiders 1.20%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 255.30M · Float 254.58M · 99.7% free float
Institutions13F, as of Jun 30, 2026
767 holders · 316.95M shares · 114 new positions · 408 increased · 233 reduced · 65 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Dodge & Cox | 37.01M | 14.50% | +534.1K | Aug 13, 2026 |
| Freemont Capital Pte Ltd | 25.36M | 9.93% | 0 | Aug 13, 2026 |
| BlackRock, Inc. | 23.18M | 9.08% | +454.1K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 16.26M | 6.37% | +17.0K | Aug 13, 2026 |
| State Street Corp | 12.34M | 4.83% | +1.05M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 11.61M | 4.55% | −114.5K | Aug 13, 2026 |
| First Eagle Investment Management, LLC | 9.41M | 3.69% | +95.0K | Aug 24, 2026 |
| Invesco Ltd. | 9.40M | 3.68% | +1.91M | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Dodge & Cox | 13.70% | 35.05M | 13G | Aug 13, 2025 ↗ |
| Winder Pte. Ltd. | 9.90% | 25.36M | 13G | Feb 14, 2025 ↗ |
| Vanguard Capital Management | 7.37% | 18.84M | 13G | Apr 30, 2026 ↗ |
| BlackRock, Inc. | 7.00% | 17.98M | 13G | Apr 24, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Paul J. Fribourg | director | 2.73M | 1.07% | Jun 2, 2026 |
| J. Erik Fyrwald | director, officer: Chief Executive Officer | 109.7K | 0.04% | May 4, 2026 |
| Deborah Borg | officer: EVP, Chief Ppl&Culture Officer | 37.9K | 0.01% | May 6, 2026 |
| Brett Icahn | director | 34.7K | 0.01% | May 4, 2026 |
| Kevin O'Byrne | director | 26.1K | 0.01% | May 4, 2026 |
| Ralf Finzel | officer: EVP, Global Operations Officer | 17.6K | 0.01% | May 6, 2026 |
| Yuvraj Arora | officer: President, Taste & CCO | 17.3K | 0.01% | May 4, 2026 |
| Stephen N. Landsman | officer: EVP, General Counsel | 17.2K | 0.01% | Apr 3, 2026 |
| Simon Herriott | officer: Pres. Health & Bioscience | 10.8K | 0.00% | Mar 6, 2025 |
| Angela Strzelecki | officer: President, Pharma Solutions | 9.6K | 0.00% | Apr 7, 2025 |
1 ten-percent owner holds 20.30M shares by Form 4, outside the officers-and-directors figure above · 56 people have not refiled in the last 18 months (25.97M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | de Mendonca Ana Paula Telesofficer: President, Scent | Sale | 5,718 | $83.19 | 0 |
| Aug 7, 2026 | Marc Birenkrantofficer: Controller & CAO | Sale | 1,000 | $85.00 | 3,446 |
| Aug 6, 2026 | Michael DeVeauofficer: EVP, CFO | Sale | 8,825 | $85.55 | 5,199 |
| Jun 1, 2026 | Paul J. Fribourgdirector | Purchase · 2 lots | 273,500 | $74.29 | 2,725,880 |
| Mar 24, 2023 | Mark J. Costadirector | Purchase | 10 | $84.27 | 10 |
| Oct 25, 2023 | Mark J. Costadirector | Sale | 15 | $66.05 | 463 |
| May 30, 2023 | Mark J. Costadirector | Sale | 15 | $77.49 | 463 |
| Aug 4, 2023 | Mark J. Costadirector | Purchase | 15 | $80.95 | 478 |
| Mar 12, 2026 | J. Erik Fyrwalddirector, officer: Chief Executive Officer | Purchase | 900 | $68.87 | 78,270 |
| Mar 13, 2026 | J. Erik Fyrwalddirector, officer: Chief Executive Officer | Purchase | 13,360 | $69.85 | 91,630 |
CongressHouse and Senate disclosures
Not reported.